You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Advanced Morphing Moulage for Medical Training (AMM-MT)
SBC: Vcom3D, Inc. Topic: DHA17A002For this Phase I SBIR proposal, Vcom3D proposes to design advanced medical moulage that accurately simulates the progression of an injury or pathology by morphing through a series of clinical states to enable learners to confirm the progression of the wound and to determine whether iatrogenic errors or pathologies occurred duing treatment. The physical morphing moulage may be applied to medical m ...
STTR Phase I 2017 Department of DefenseDefense Health Program -
A Randomized Blinded Placebo Controlled Clinical Trial to Evaluate Longeveron Mesenchymal Stem Cell LMSC Therapy for Treating The Metabolic Syndrome
SBC: Longeveron LLC Topic: NIAThe metabolic syndrome MetS is a cluster of factors that increases the risks for cardiovascular disease type diabetes mellitus and mortality and currently affects andgt of US adults MetS is associated with endothelial dysfunction decreased circulating endothelial progenitor cells EPCs and a pro inflammatory state We have made the exciting discovery that therapy with allogeneic me ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Compatibility Between Brain Computer Interface and High Efficiency Augmentative and Alternative Communication Systems
SBC: Prentke Romich Company Topic: NIDCDCompatibility Between Brain Computer Interface and High Efficiency Augmentative and Alternative Communication Systems ABSTRACT Brain computer interfaces BCI can now enable text production for people who cannot move yet they provide only the simplest communication interfaces and have not been widely adopted Current augmentative and alternative communication AAC systems are widely adopted and ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Developing a novel therapy for diabetic retinopathy
SBC: Everglades Biopharma, LLC Topic: WProject Summary Diabetic retinopathy DR is a leading cause of vision loss affecting about million people worldwide A major breakthrough in DR therapy is the recent approval of vascular endothelial growth factor VEGF inhibitors However anti VEGF therapy has limited efficacy with a number of side effects The critical barrier is how to identify other angiogenic targets for alternative or ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Developing a small peptide to control autoimmune inflammation in type diabetes
SBC: Op-T-Mune, Inc Topic: NIAIDAbstract Type Diabetes T D affects an ever growing population While this disease typically has been associated with juveniles the disease in adult populations is rapidly increasing The defining clinical component is insulin loss which occurs because of sustained inflammation in the islets At present there is no means to prevent or reverse insulin loss A major inflammatory pathway in T D ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of a Clinical Screening Platform for Type Diabetes
SBC: Op-T-Mune, Inc Topic: NIDDKAbstract A major shortfall in clinical care for diabetes is a rapid and accurate screen for progression to disease Current criteria involve HLA haplotype and the presence of auto antibodies AA Genome wide associated studies GWAS revealed only immune associated genes including HLA as T D predictors The ability to differentiate from other diseases was very limited Pre type diabetes p T ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
DRα MOG A Novel Immunomodulatory Therapeutic for Stroke
SBC: Virogenomics BioDevelopment Inc Topic: 105This is a Phase I STTR to investigate the preclinical efficacy of a novel immunomodulator DR MOG in a clinically relevant thromboembolic stroke model in mice We have previously shown that T cells are activated after stroke infiltrate brain and exacerbate ischemic brain damage Strategies that reduce T cell activation and brain tissue infiltration have been investigated as potential therapeu ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Dynamic virtual moulage based on thin film adhesive displays
SBC: ARCHIE MD INC. Topic: DHA17A002Providing Army combat medics with meaningful experience in treatment of battlefield injuries is a particular challenge. Moulage has the potential to assist in acquiring what could otherwise be very hard-to-come-by preparatory experience for the distressing real-life emergencies medics and soldiers may encounter in the field. However, current approaches to moulage are limited in their ability to re ...
STTR Phase I 2017 Department of DefenseDefense Health Program -
Electrotextile Systems for Human Signatures Monitoring
SBC: Mantel Technologies, Inc. Topic: DHA17A001Investments by the Department of Defense (DOD) have led to the development and demonstration of electronic textiles capable of transforming traditional textile systems into wearable power and data systems. The Defense Health Agency (DHA) has identified an opportunity to leverage advancements in smart garment systems for military personnel to aid in the prediction in performance declines and healt ...
STTR Phase I 2017 Department of DefenseDefense Health Program -
Enhanced WAAVES+: A Fast and Accurate Automated USV Scoring Program
SBC: Cornerstone Research Group, Incorporated Topic: DHP16C003Cornerstone Research Group (CRG) and the University of Texas (UT) will team to develop a fast and accurate automated analysis program for USV scoring. This automated tool will enable greater research efficiency and throughput allowing greater strides in developing treatments for post-traumatic stress disorder through rodent-based research. Building off prior work by UT on a first generation auto-s ...
STTR Phase I 2017 Department of DefenseDefense Health Program